Neuronetrix announces FDA approval of COGNISION System for clinical usehealthmedicinetFebruary 21, 2015news / no comments Neuronetrix Related posts: HMN 2025: How Clinical trial leads to FDA approval of drug for rare, deadly blood cancer HMN 2025: How FDA grants accelerated approval for first treatment for Barth syndrome Previous Post Physiotherapy Associates, Performance Health partner to deliver TheraBand Active Care System Next Post Tandem Diabetes Care announces release of t:simulator App
